Print

Global: To Optimize the Performance of a Novel Instrument-free, Point-of-Care Molecular Diagnostic Test for SARS-CoV-2
Details
Locations:USA
Start Date:Jul, 2020
End Date:Jan, 2021
Contract value: USD 99,274
Sectors: Health, Research & Innovation
Description
Purpose: To optimize the performance of a novel instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2
Division: Global Health
Region served: GLOBAL
Grant topic: Enterics, Diagnostics, Genomics & Epidemiology
Duration (months): 6
Grantee location: Los Angeles, California, United States

